chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She presents today for a telemedicine appt with concern for left arm pain after COVID booster over a month ago. She states she got her injection and within 1 week she had worsening arm pain. By the second week she states she had tingling in the arm from the mid-upper arm down toward the wrist. She denies any ROM difficulty of the shoulder, elbow, wrist; denies skin changes or swelling to any site on the arm. She states it is difficult to move her arm sometimes-- like for instance she got her arm stuck trying to get herself out of her robe a few days ago and her daughter had to help her with it. Nothing she has tried helps for it, and it's not getting any better.   She states she called a few days ago with concerns (here, to this clinic) and was told to take 'aspirin or NSAID' but it didn't help.   Ordered US of left arm, pt referred to physical therapy due to mobility concerns, given Celebrex 100 mg PO QD. Would refer to ortho if not improving.
Information has been received from a pharmacist concerning a 76 years old male patient, who on 27-SEP-2012 was vaccinated with a dose of ZOSTAVAX (dose, route and lot # not reported). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on 27-SEP-2012 the patient bled little along with some of the solution from ZOSTAVAX at the injection site. At the time of reporting the outcome of the event was unknown. Additional information has been requested.
pt recv vax 12MAR98 & same day devel dizziness, fever & was bedridden for 1 day;pt was not treated for the event & it is unk whether or not hep b was discontinued;
Localized rash around injection site.  Next morning patient developed myalgias and fever highest 101.5 and controlled with Tylenol.
Severe body aches; joing pain; shivering, couldn't get warm; arm pain; severe headache; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Aug2022 at 10:00 as dose 4 (booster), single (Lot number: FP7137) at the age of 54 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Coeliac disease" (unspecified if ongoing); "Gluten allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose number=3, lot number: FE3590, administration time: 12:00 PM, Left arm), administration date: 28Oct2021, when the patient was 54-year-old, for Covid-19 immunization, reaction(s): "Severe body aches", "Joint pain", "Shivering", "Pain in arm", "Headache"; BNT162b2 (Dose 2, lot number: EL1284), administration date: 13Jan2021, when the patient was 53-year-old, for Covid-19 immunization, reaction(s): "Severe body aches", "Joint pain", "Shivering", "Pain in arm", "Headache"; BNT162b2 (Dose 1, lot number: EJ1685), administration date: 23Dec2020, when the patient was 53-year-old, for Covid-19 immunization, reaction(s): "Severe body aches", "Joint pain", "Shivering", "Pain in arm", "Headache". The following information was reported: PAIN (non-serious) with onset 09Aug2022 at 20:00, outcome "recovering", described as "Severe body aches"; PAIN IN EXTREMITY (non-serious) with onset 09Aug2022 at 20:00, outcome "recovering", described as "arm pain"; ARTHRALGIA (non-serious) with onset 09Aug2022 at 20:00, outcome "recovering", described as "joing pain"; HEADACHE (non-serious) with onset 09Aug2022 at 20:00, outcome "recovering", described as "severe headache"; CHILLS (non-serious) with onset 09Aug2022 at 20:00, outcome "recovering", described as "shivering, couldn't get warm".
This spontaneous report (initial receipt: 08-FEB-2011) concerns a 13 year old female patient, who had a medical history of asthma, environment allergies and an anxiety disorder.  The patient did not have any illness at the time of vaccination.  On 27-OCT-2008 the patient received a Flu vaccine (brand name unspecified).  The patient also received intramuscular GARDASIL (batch number: 0279X) on the same day.  She received her third dose of GARDASIL (batch number: 0570X) on 26-MAY-2009.  On 09-MAR-2009, 134 days after flu vaccination, the patient was found to have elevated optic nerve (on examination).  Subsequently she had a positive ANA test twice and elevated anti-SSB antibody associated with Sjogren's syndrome, but no eye symptoms.  The patient outcome was not provided.
Pt reports L arm redness & swelling at vaccine site started on 9/10/11 (9 days after Covid vaccine). Benadryl taken with no improvement. Pt saw allergist on 9/14/21 & was advised to take Xyzal, Allegra, and Famotidine which she took last night with some improvement noted today
1 week after patient received vaccine, the patient presented in office with cough, congestion and sore throat. COVID-19 test performed and was negative, pt had not traveled or had any known or suspected exposure,  Patient was dx with rhinitis and allergies.
Patient experienced a red penny sized bump above the injection site immediately after receiving the vaccine. Patient was monitored for an additional 30 minutes and no other effects were observed.  Patient was given Benadryl and has seen felt normal with no further symptoms except a sore arm
joints are really killing him and joints are starting to retain water or fluid on caller's knee and shoulder joints.; This spontaneous case was reported by a consumer and describes the occurrence of JOINT EFFUSION (joints are really killing him and joints are starting to retain water or fluid on caller's knee and shoulder joints.) in a male patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced JOINT EFFUSION (joints are really killing him and joints are starting to retain water or fluid on caller's knee and shoulder joints.). At the time of the report, JOINT EFFUSION (joints are really killing him and joints are starting to retain water or fluid on caller's knee and shoulder joints.) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       Concomitant medication was not reported. Patient reported that his joints are really killing him and joints are starting to retain water or fluid on his knee and shoulder joints. Patient's mother took Pfizer vaccine and had no problems. Treatment information was not reported.   Reporter did not allow further contact
Pain at injection site; Headache; Nausea; Vomiting; Loss of appetite; Fatigue; Chills; This is a spontaneous report from a non-contactable nurse (patient herself).  This 35-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL3248), via intramuscular, on 09Jan2021 at 10:30, at single dose in the left arm, for COVID-19 immunisation. The patient was not pregnant. She was vaccinated at hospital, age at vaccination was 35-year-old. The patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL5730), via intramuscular, on 19Dec2020 at 13:00 at single dose in the right arm. Historical vaccine includes Hepatitis A vaccine (single dose, via an unknown route in the arm left) on 18Dec2020. No medical history was provided. No known allergies. No relevant concomitant medications were provided. The patient was vaccinated at hospital, age at vaccination was 35-year-old. Pre-vaccination and post-vaccination COVID tests were not performed. On 09Jan2021 at 18:00, the patient developed pain at injection site, headache, nausea, vomiting, loss of appetite, fatigue, and chills. The patient was not treated for the events. The patient had recovered from the events on unknown date in Jan2021.  No follow-up attempts are possible. No further information expected.
Information has been received from a consumer and a school nurse concerning 41 child patients who in approximately 1995 were each vaccinated with a dose of varicella virus vaccine live. In approximately 2003, the patients developed mild cases of chickenpox.  Most of the children were in the first grade and had been vaccinated at their private pediatrician's offices in the area. The reporter noted that her elementary school was the only one out of six in the area that has experienced a chickenpox outbreak. The reporter notified the elementary school parents of the outbreak. Follow up information from the nurse indicated that 13 of the reported 41 patients were not previously vaccinated with a dose of varicella virus vaccine live and all of the cases of chickenpox have recovered. One of the previously vaccinated patients was a 7 year old patient who on 28NOV1996 was vaccinated with a dose of varicella virus vaccine live. On 12MAR2003, the patient developed chickenpox. The previously vaccinated patients included two siblings in elementary school who were vaccinated by the same pediatrician and subsequently developed mild outbreaks of chickenpox. The other patients that developed chickenpox post vaccination with varicella virus vaccine live were also identified.  Additional information is not expected.
Customer called for the first time on Saturday, April 29th. He said his forehead and eyelid were itchy. He at first said it started on Thursday. After asking if it could be due to something else, he later stated that maybe it started earlier in the week to a smaller degree and he is just now noticing it. He also has had a headache all week and has felt fatigued.  He will also call his doctor.
Pt called Clinic call center on 4/26/21 . Pt got 1st dose Moderna vaccine on 4/16/21. Pt complains of red, swollen tonsils and painful when swallowing. Red, rash, swelling and hot at injection site. Lymph nodes at armpit also swollen. Onset of symptoms 4/23/21. Pt states she took antihistamine for the rash. Advised pt to go to ED for evaluation and pt verbalized understanding.
Body aches, muscle pains, feeling fatigued, wore out, ran down, HEADACHE, nose bleed (unsure if related)
diarrhea; This is a spontaneous report from a contactable consumer (patient).  A 60-year-old male patient, who was also 60-year-old at the time of vaccination, received first dose of bnt162b2 (BNT162B2), lot number not reported, via an unspecified route of administration on left arm from 15Jan2021 14:00 as dose for COVID-19 immunisation.  The patient medical history was not reported.  There were no concomitant medications.  The patient received second dose of BNT162B2 on 05Feb2021 at 02:00 PM on left arm. On 18Jan2021 10:00, patient experienced diarrhea with outcome of not recovered. Therapeutic measures were taken as a result of diarrhea which includes Imodium.  Information regarding the lot/batch number has been requested.
The tinnitus I have in both ears that I recently developed (potentially due to an early Covid infection became much louder and screeching.
immed p/vax mom states lump appeared behind ear;parents state that it could have been there a/vax;rash appeared that noc on head & back, now on belly & axillae;congestion, clear mucous, had fever 102 @ home;afeb today;
bronchitis or pneumonia; pain down arm into fingers; injection site tingling; Chest felt heavy and difficulty breathing; Chest felt heavy and difficulty breathing; bronchitis or pneumonia; rash on both arms with bright purple skin; rash on both arms with bright purple skin; felt like everything was numb and like she was on drugs; felt like everything was numb and like she was on drugs; Severe headache; This is a spontaneous report from a contactable consumer (nurse) via a Pfizer sales representative.  A female patient of an unspecified age received the first dose of the bnt162b2 (BNT162B2; also reported as COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported. On an unspecified date, the patient experienced: bronchitis or pneumonia (medically significant), pain down arm into fingers, injection site tingling, chest felt heavy and difficulty breathing, rash on both arms with bright purple skin, felt like everything was numb and like she was on drugs, and severe headache; all of which required hospitalization. The clinical course was reported as follows: The female patient (nurse) took the first dose of the vaccine and experienced pain down arm into fingers, injection site tingling. The patient's chest felt heavy and difficulty breathing; however, the "tongue never swelled." Rapid response was called, and the patient was taken to the hospital. The patient was given a "cocktail" to treat the reaction. The patient "felt like everything was numb and like she was on drugs" The patient also felt like she had bronchitis or pneumonia. The patient also experienced a "rash on both arms with bright purple skin"; along with a severe headache. Therapeutic measures were taken as a result of pain down arm into fingers, injection site tingling, and chest felt heavy and difficulty breathing. The clinical outcome of the events was unknown.  No follow-up attempt possible; information about batch/lot number cannot be obtained.
Patient received Hepatitis A, IPV, and Td and left the nurses office.   The nurse observed that the father was supporting the patient and she was returned back to the nurse's office for further assessment.  Presented with diaphoresis, pale, general malaise, yet alert responsive and able to answer questions about how she was feeling.  Parents reported that she was really apprehensive about having to get vaccines today.  O2 SATS 77-86%, BP WN range.  Patient was able to ambulate with parents out of the office.  With instructions to parents to report to the ER if any further attention is warranted and parents verbalized understanding with the interpreter.
Pt recvd DTP @ clinic on 21FEB90; Around 2400 pt awoke & was fussy & crying; @ 0400-0500 devel generalized convuls described as rhythmic contractions of both extremities & rotating head back & forth; To ER post-ictal state w/t107F;
Patient received first dose of moderna vaccine at vaccination site and started dry heaving/vomiting and then passed out. Then she had seizure and was brought to ER.
PATIENT STATED HE WAS COVID POSITIVE 1 WEEK AFTER RECEIVING VACCINE. HE WAS NOT HOSPITALIZED AND COMPLETED QUARANTINE AND WAS COUNSELED. HE DID NOT RECEIVE ANY ANTIBODIES FOR TREATMENT OF COVID-19.  HE PLANS TO RECEIVE HIS SECOND DOSE ON 4/15/21.
Patient reports feeling  like she almost needs to use her albuterol inhaler.  Short of breath.  Also, said she has a stuffy nose that is not relieved by her fluticasone nasal spray.  She noticed this shortly after receiving her vaccine and continuing to the next morning.
Some of the dose was lost and not administered; Malfunction of syringe and needle; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (Some of the dose was lost and not administered) and DEVICE CONNECTION ISSUE (Malfunction of syringe and needle) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced UNDERDOSE (Some of the dose was lost and not administered) and DEVICE CONNECTION ISSUE (Malfunction of syringe and needle). At the time of the report, UNDERDOSE (Some of the dose was lost and not administered) and DEVICE CONNECTION ISSUE (Malfunction of syringe and needle) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided  No treatment medications were provided.
First day experienced extreme fatigue and could not function.  Have also experienced extreme headaches and unexplainable crying spells.  My arm of injection is still sore, although not all of the time.   The extreme fatigue hits hard and causes me to lay down to sleep.  Headaches are rare for me, but now  are common.  The crying spells are extreme, and are the same as when my endocrine glands stopped working 5 years ago. . Now Day 8 and these symptoms are continuing and waking me up.
Information has been received from a healthcare professional concerning a 71-year-old male, with a history of chickenpox, who on 04-JAN-2008 was vaccinated subcutaneous in the right deltoid with his first 0.65 ml dose of ZOSTAVAX (Merck) (lot # 658867/1413U).  There was no recent exposure to chickenpox or herpes zoster.  On approximately 10-JAN-2008, 6 days post vaccination, the patient developed shingles on the left side (ribs).  The patient sought unspecified medical attention.  On 25-JAN-2008 the patient recovered.  A product quality complaint was not involved.  Additional information has been requested. This is in follow-up to report (s) previously submitted on 3/26/2008. The event was considered non serious. Further information is not expected.
Two days after vax with Dtap the right thigh became swollen and red. Baby was also irritable. Symptoms lasted two days.
Patients that were vaccinated with this vaccine after the excursion; No adverse event; Patients that were vaccinated with this vaccine after the excursion; This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients that were vaccinated with this vaccine after the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event) in a 61-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7162B) for COVID-19 prophylaxis.     It was unknown if patient had any acute illness at the time of the vaccination or up to one month before.  It was unknown if any prescriptions, over-the-counter medications, dietary supplements, or herbal remedies were being taken at time of vaccination and/or at the time of the adverse event.  It was unknown if patient was diagnosed or tested positive with COVID-19.  Concurrent medical conditions included Asthma and Depression.    On 05-Oct-2022 at 10:19 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) .5 milliliter. On 05-Oct-2022 at 10:19 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients that were vaccinated with this vaccine after the excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients that were vaccinated with this vaccine after the excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Patients that were vaccinated with this vaccine after the excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patients that were vaccinated with this vaccine after the excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients that were vaccinated with this vaccine after the excursion).    No concomitant medication reported. No treatment medication reported.  The reporter wanted to know the recommendation for the patients. No adverse events were reported.
Red swollen bump at injection reappeared yesterday.  Currently monitoring growth.  Bump is red, raised and warm
11:00 pm chills, the next day major headache & chills & achy all over. Wednesday 3;00 am chills took more Tylenol then 6:00am  sweats. then noticed welt on my arm 5 inches from shot location & hives on stomach. Every now & then I felt like I was going to pass out if I stood up. Thursday felt stronger by the afternoon no more chills since Wednesday after the sweats. Still have welt on arm that appears to be spreading & still have hives on stomach. Was taking Benadryl for rash. Friday still have rash . Saturday rash & hives seem to be fading.
When the certified immunization tech was administering the vaccine the vaccine began to leak out of the joint where the needle attaches to the syringe barrel. The tech immediately withdrew the needle from the patients arm, informed that patient that the syringe had malfunctioned, and went to get the pharmacist. Approximately half of the dose remained in the syringe, unclear if any amount of the vaccine was successfully administered to the patient. Patient was informed that we could not proceed with the vaccination. Per manufacturer/our clinical team we were informed to administer another full dose to the patient and then a second dose 28 days later to complete the vaccine series. Patient has already set up appointment with us for today to complete the vaccine.
Headache, Myalgia & NauseaVomiting Narrative:  Stated mild reaction from Covid 1, 2, and now the 3rd dose
Mother reports pt having difficulty swallowing, breathing and diarrhea in evening of injections, the next day c/o feeling hot, tired, and still slight trouble breathing. Not taken to ER/clinic, FHN advised to take to an emergency with trouble breathing or respiratory problems. Advised to have td/hep A only under medical care.
Experienced blood in urine in the morning on 5/12/2021., approx 16 hours after receiving second dose. No uti symptoms present.  Also experiencing intensifying kidney paid  n.
Site: Bruising at Injection Site-Medium, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Additional Details: Nodule and red formed at injection site immediately after administration. patient reported no breathing issue or pain. She sat for 15 minutes at the round swelling went down. She said she felt okay. Couseled to monitor that night for other s/s of allergic rxn. Called patient the next day to follow up. She has bruising but no other issues. Swelling and redness is gone.
This spontaneous report as received from a nurse practitioner refers to a 12 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 07-JAN-2015, the patient was vaccinated with the dose of PEDVAX HIB lot # K008874 (dose, strength, route of administration and expiration date were not reported) which had temperature excursion. No information on patient's concomitant medication was provided. This is one of several reports from the same reporter. Additional information has been requested.
I had flu like symptoms starting about 6 to 8 hrs after the injection including 101 degree fever, chills, body aches. These symptoms lasted for for 24 to 36 hrs. I took tylenol and fruit juice. Fever reduced to 99 degrees after 24 hrs and all symptoms were completely gone after 48 hrs. I did not seek medical treatment. I looked online and found this was a common reaction especially to the 2nd dose of the vaccine.
PATIENT PRESENTED TO THE PHARMACY TODAY AT 10:25AM STATING THAT SHE HAD AN ALLERGIC REACTION TO THE FLU SHOT GIVEN ON 9/9/20. HER SYMPTOMS WAS STOMACH HURTS, REDNESS AT THE INJECTION SITE. THE ER GAVE HER PREDNISONE AND PEPCID. VISUALLY TODAY, MRS IS NOT SHOWING ANY ALLERGIC REACTIONS ON HER ARMS, NECK FACE ETC. AND STATES THAT SHE FELLS GOOD.